The Compensation Committee aims to assist the Board of Directors in implementing and evaluating the company's overall compensation and benefits policies, as well as the remuneration of directors and executives.

The Audit Committee assists the Board in fulfilling its oversight of the quality and integrity of the accounting, auditing, reporting, and financial control practices of the Company. The Audit Committee is responsible to review the Company’s: financial reports; auditing and accounting policies and procedures; internal control systems; material asset or derivatives transactions; material lending funds, endorsements or guarantees; offering or issuance of any equity-type securities; legal compliance; hiring or dismissal of an attesting CPA, etc. TaiMed’s Audit Committee consist of all independent Directors and Professor Chin-Ting Chiu serves as the chairman of committee. Please consult TaiMed’s Annual Report for the relevant year for the number of meetings convened and each member’s attendance rate.

Chairman Chiu, Chin-Ting

  • MBA, National Taiwan University
  • chairman, Securities and Futures Investors Protection Center
  • member of Mediation Committee, Securities and Futures Investors Protection Cente

Member Howard S. Lee, Ph.D.

  • PhD in Chemistry, University of Southern California, USA
  • Partner, The CID Group
  • Chairman, Easywell Biomedicals, Inc.
  • Chairman, TAHO Pharmceuticals, Ltd.
  • Chairman, Transwell Biotech CO., Ltd.

Member Gwo-Fong Lin, Ph.D

  • Doctor of Philosophy in Engineering, University of Pittsburgh
  • Distinguished Professor, National Taiwan University
  • Corresponding Member, International Academy of Engineering, Russi